Chronic Heart Failure
Reports outline chronic heart failure research from University of Colorado
Published in Genetics and Environmental Law Weekly, March 6th, 2010
"Bucindolol is a novel beta-AR blocking agent that also lowers systemic norepinephrine and thus is also a sympatholytic agent. This study investigated whether alpha(2C)-AR polymorphisms affect sympatholytic effects of bucindolol in patients with heart failure. In the beta-Blocker Evaluation of Survival Trial, adrenergic activation was estimated by systemic venous norepinephrine measured at baseline, 3...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Law Weekly
More Articles from Genetics and Environmental Law Weekly
- 454 Life Sciences
Research Team Publishes World's First Southern African Genome and Multiple Exomes using Technology from 454 Life Sciences and Roche NimbleGen - Abdominal Aortic Aneurysm
Data on abdominal aortic aneurysm described by researchers at Karolinska University - Abdominal Aortic Aneurysm
Studies from University of Paris, Cardiovascular Research Center describe new findings in abdominal aortic aneurysm - Adenoma
Researchers from Cleveland Clinic report details of new studies and findings in the area of adenoma - Age and Aging
Reports outline age and aging study findings from Princeton University - Age and Aging
Reports summarize age and aging study results from University of California, Department of Psychiatry - More from this issue of Genetics and Environmental Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
